Bone diseases: Romosozumab-on track or derailed?

Sundeep Khosla

doi:10.1038/nrendo.2017.136

Bone diseases: Romosozumab-on track or derailed?

Sundeep Khosla

Endocrinology, Diabetes, Metabolism, and Nutrition

Research output: Contribution to journal › Short survey › peer-review

12 Scopus citations

Original language	English (US)
Pages (from-to)	697-698
Number of pages	2
Journal	Nature Reviews Endocrinology
Volume	13
Issue number	12
DOIs	https://doi.org/10.1038/nrendo.2017.136
State	Published - Dec 1 2017

ASJC Scopus subject areas

Endocrinology, Diabetes and Metabolism
Endocrinology

Access to Document

10.1038/nrendo.2017.136

Cite this

@article{217695c14e564113be7c59d1ed191897,

title = "Bone diseases: Romosozumab-on track or derailed?",

author = "Sundeep Khosla",

note = "Funding Information: The author{\textquoteright}s work is supported by NIH grants AG004875, AG048792 and AR027065. In addition, the author greatly appreciates the critical review of this article by M. Drake and J. Farr.",

year = "2017",

month = dec,

day = "1",

doi = "10.1038/nrendo.2017.136",

language = "English (US)",

volume = "13",

pages = "697--698",

journal = "Nature Reviews Endocrinology",

issn = "1759-5029",

publisher = "Nature Publishing Group",

number = "12",

}

TY - JOUR

T1 - Bone diseases

T2 - Romosozumab-on track or derailed?

AU - Khosla, Sundeep

N1 - Funding Information: The author’s work is supported by NIH grants AG004875, AG048792 and AR027065. In addition, the author greatly appreciates the critical review of this article by M. Drake and J. Farr.

PY - 2017/12/1

Y1 - 2017/12/1

UR - http://www.scopus.com/inward/record.url?scp=85033229429&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85033229429&partnerID=8YFLogxK

U2 - 10.1038/nrendo.2017.136

DO - 10.1038/nrendo.2017.136

M3 - Short survey

C2 - 29027994

AN - SCOPUS:85033229429

SN - 1759-5029

VL - 13

SP - 697

EP - 698

JO - Nature Reviews Endocrinology

JF - Nature Reviews Endocrinology

IS - 12

ER -

Bone diseases: Romosozumab-on track or derailed?

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this